Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
Year: 2009
Type: review
Source: Nature reviews. Cancer
DOI: 10.1038/nrc2656
Authors: José Baselga, Sandra M. Swain
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: GlaxoSmithKline, Array BioPharma
OpenAlex ID: W1993804787